Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01183455
Show Display Options
Rank Status Study
1 Withdrawn A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Aralast NP;   Drug: Placebo

Indicates status has not been verified in more than two years